Showing results (151-160 of 175) with videos related to
Sort By:
Pageof 18
Annals of the Rheumatic Diseases|February 25, 2015
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosusTobias Alexander, Ramona Sarfert, Jens Klotsche, et al.Journal of Molecular Medicine (Berlin, Germany)|March 31, 2017
Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic optionsRomy Strauß, Thomas Rose, Shaun M Flint, et al.Kidney International|June 28, 2020
Nuclear antigen-reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneysDimas Abdirama, Sebastian Tesch, Anna-Sophie Grießbach, et al.RMD Open|January 4, 2023
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic diseaseLeonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, et al.RMD Open|February 6, 2023
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodiesSophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, et al.Molecular & Cellular Proteomics : MCP|January 2, 2025
Multitiered Proteome Analysis Displays the Hyperpermeability of the Rheumatoid Synovial Compartment for Plasma ProteinsEva Maria Stork, Sofia Kalaidopoulou Nteak, Danique M H van Rijswijck, et al.Molecular & Cellular Proteomics : MCP|March 5, 2011
Fc-glycosylation of IgG1 is modulated by B-cell stimuliJun Wang, Crina I A Balog, Kathrin Stavenhagen, et al.Clinical and Experimental Rheumatology|November 30, 2020
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational toolsGerd-Rüdiger Burmester, José María Álvaro-Gracia, Neil Betteridge, et al.Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.Nature Communications|April 10, 2024
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritisEva Maria Stork, Danique M H van Rijswijck, Karin A van Schie, et al.Pageof 18